Stenting for middle aortic syndrome caused by Takayasu arteritis‐immediate and long‐term...
Che, Wuqiang; Xiong, Hongliang; Jiang, Xiongjing; Dong, Hui; Zou, Yubao; Yang, Yuejin; Gao, Runlin
2018-01-15 00:00:00
INTRODUCTIONTakayasu arteritis (TA) is a relatively uncommon chronic nonspecific inflammatory disease of unknown etiology that mainly affects the aorta and its major branches . The inflammatory process creates structural changes that lead to wall thickening, fibrosis, and stenosis . Stenosis is the most common vascular lesion of TA , and significant stenotic lesions of the distal thoracic or abdominal aorta may result in middle aortic syndrome (MAS) , which manifests as lower limb ischemia, hypertension, myocardial hypertrophy, heart failure, hemorrhagic stroke , or even death. Historically, the management of such lesions involved with TA has been that of anti‐inflammatory therapy and open surgical techniques. However, the open surgical approach is technically challenging due to its complexity with multiple vessel involvement and is associated with high rates of procedural and periprocedural complications, such as postoperative anastomotic aneurysm formation, and graft occlusion . Due to these challenges, percutaneous transluminal angioplasty (PTA) has gained popularity as the preferred treatment method in suitable patients . However, major concerns such as obstructive dissection and long‐term patency along with PTA alone still exist . Hence, some case reports and retrospective studies evaluated the feasibility of stenting for the treatment of this condition. However, related data
http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.pngCatheterization and Cardiovascular InterventionsWileyhttp://www.deepdyve.com/lp/wiley/stenting-for-middle-aortic-syndrome-caused-by-takayasu-arteritis-yqYuTS00pg

Abstract

INTRODUCTIONTakayasu arteritis (TA) is a relatively uncommon chronic nonspecific inflammatory disease of unknown etiology that mainly affects the aorta and its major branches . The inflammatory process creates structural changes that lead to wall thickening, fibrosis, and stenosis . Stenosis is the most common vascular lesion of TA , and significant stenotic lesions of the distal thoracic or abdominal aorta may result in middle aortic syndrome (MAS) , which manifests as lower limb ischemia, hypertension, myocardial hypertrophy, heart failure, hemorrhagic stroke , or even death. Historically, the management of such lesions involved with TA has been that of anti‐inflammatory therapy and open surgical techniques. However, the open surgical approach is technically challenging due to its complexity with multiple vessel involvement and is associated with high rates of procedural and periprocedural complications, such as postoperative anastomotic aneurysm formation, and graft occlusion . Due to these challenges, percutaneous transluminal angioplasty (PTA) has gained popularity as the preferred treatment method in suitable patients . However, major concerns such as obstructive dissection and long‐term patency along with PTA alone still exist . Hence, some case reports and retrospective studies evaluated the feasibility of stenting for the treatment of this condition. However, related data

Journal

Catheterization and Cardiovascular Interventions
– Wiley

Published: Jan 15, 2018

Keywords: ; ; ; ;

Recommended Articles

Loading...

References

Large vessel vasculitides: Update for the cardiologist

Luqmani, R.

Medium‐ and large‐vessel vasculitis

Weyand, CM; Goronzy, JJ.

Clinical manifestations and longterm outcome for patients with Takayasu arteritis in China